Texas Instruments Inc. (0R2H)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 279.30 |
|---|---|
| 52-week range | 149.95 – 339.13 |
| Return, 1 month / 3 months | +3.9% / −4.6% |
| Return, 1 year / 3 years | +63.1% / +91.8% |
| Trend | Uptrend |
| RSI (14) | 51 |
| Volatility (1 year) | 41.5% |
| Worst drawdown (1 year) | -23.4% |
| Average daily value traded | 1.62M USD |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Texas Instruments is a semiconductor company that designs and makes analog chips and embedded processors, the small circuits that manage power, convert signals and control devices. Its customers are manufacturers of industrial equipment, automobiles, personal electronics and communications gear, who build these chips into their own products. The company is based in Dallas, Texas, in the United States, and it also supplies calculators and other educational tools.
Texas Instruments Inc. trades under the code 0R2H on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Texas Instruments Inc. (0R2H) trades on the London Exchange in UK. It last closed at USD 279.30 on 20 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,074 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 63.1% and over the last three months it fell 4.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 10.3% | ||
| From 52-week high | -14.8% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -4.6% | ||
| 6-month return | 21.3% | ||
| 12-month return, skipping the last month | 57.0% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.4% | ||
| Liquidity | 58 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.62M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 6 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.4% |
|---|---|
| 1 month | +3.9% |
| 3 months | −4.6% |
| 6 months | +21.3% |
| 1 year | +63.1% |
| 3 years | +91.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 271.98 / 253.27 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.61 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jul 2026 | USD 1.4200 |
| 1 May 2026 | USD 1.4200 |
| 29 Jan 2026 | USD 1.4200 |
| 30 Oct 2025 | USD 1.4200 |
| 30 Jul 2025 | USD 1.3600 |
| 29 Apr 2025 | USD 1.3600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.